@article{89552c6666d04777a36d977fb33e32f8,
title = "Response to the correspondence: “Non-optimal methodology questions indirect treatment comparison of dupilumab vs other biologics in severe asthma”",
keywords = "Benralizumab, Dupilumab, Indirect treatment comparison, Matching-adjusted indirect comparison, Mepolizumab, Severe eosinophilic asthma",
author = "Bateman, {Eric D.} and Khan, {Asif H.} and Yingxin Xu and Patricia Guyot and Jingdong Chao and Siddhesh Kamat and Paul Rowe and Heather Burnett and Jerome Msihid and David Weinreich and Pavord, {Ian D.}",
note = "Funding Information: The authors received editorial support in the preparation of this manuscript provided by Martina Fuchsberger, PhD, of Excerpta Medica, funded by Sanofi Genzyme and Regeneron Pharmaceuticals, Inc .",
year = "2022",
month = jan,
doi = "10.1016/j.rmed.2020.106088",
language = "English",
volume = "191",
journal = "Respiratory Medicine",
issn = "0954-6111",
}